As a result, women with the CHEK2 c.1100delC variant have a moderately increased risk of breast cancer, which further increases with a positive family history of breast cancer.8 9 Therefore, diagnostic testing for the c.1100delC variant was initiated in the Netherlands in 2014. Here, CHEK2 is linked to breast carcinoma.